Literature DB >> 1084354

Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency. Evidence against a stem cell defect.

R H Buckley, R B Gilbertsen, R I Schiff, E Ferreira, S O Sanal, T A Waldmann.   

Abstract

Surface markers typical of T and B lymphocytes were present on varying proportions of peripheral blood lymphocytes from three infants with severe combined immunodeficiency disease. Despite this, functions mediated by T and B cells were either absent or very minimal in all three, including cell-mediated responses in vivo; the in vitro proliferative response to mitogens, allogeneic cells, or antigens; effector cell function in lymphocyte-antibody lymphocytolytic interaction assays; and in vitro synthesis of IgG, IgA, and IgM. In contrast, mononuclear cells from one of the infants were tested and found capable of lysing both human and chicken antibody-coated erythrocyte targets normally. Co-cultivation experiments with unrelated normal control lymphocytes failed to demonstrate suppressor cell activity for immunoglobulin synthesis in these infants. Augmentations of immunoglobulin production from 310 to 560% over that expected on the basis of individual culture data were noted in co-cultures of one of the infants' cells with two different unrelated normal control cells. These findings suggest that that infant may have had a T helper cell defect or that his T cells were unable to produce soluble factors necessary for B cell differentiation. The finding of cells with differentiation markers characteristic of T and B lymphocytes in each of these patients, though in variable quantities, is further evidence for heterogeneity among patients with the clinical syndrome of severe combined immunodeficiency and argues against the concept that their immunodeficiency was due to a stem cell defect.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084354      PMCID: PMC333163          DOI: 10.1172/JCI108441

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Correction of severe combined immunodeficiency by fetal liver cells.

Authors:  R H Buckley; K J Whisnant; R I Schiff; R B Gilbertsen; A T Huang; M S Platt
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

2.  Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A.

Authors:  G Trinchieri; M De Marchi; W Mayr; M Savi; R Ceppellini
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

3.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

4.  Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease.

Authors:  K W Pyke; H Dosch; M M Ipp; E W Gelfand
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

5.  Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency.

Authors:  R I Schiff; R H Buckley; R B Gilbertsen; R S Metzgar
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

Review 6.  Developmental defects of T and B cell lines in humans.

Authors:  M D Cooper; R G Keightley; L Y Wu; A R Lawton
Journal:  Transplant Rev       Date:  1973

7.  Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973.

Authors:  H J Meuwissen; B Pollara; R J Pickering
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

8.  Antibody-dependent lymphocyte killer function in human immunodeficiency diseases.

Authors:  G S Rachelefsky; P R McConnachie; A J Ammann; P I Terasaki; E R Stiehm
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

9.  Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency.

Authors:  S H Polmar; E M Wetzler; R C Stern; R Hirschhorn
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

10.  Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity.

Authors:  E R Giblett; A J Ammann; D W Wara; R Sandman; L K Diamond
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

View more
  18 in total

Review 1.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  Severe T lymphocyte immunodeficiency associated with hypogammaglobulinemia: defective lymphokine secretion but enhanced autologous mixed lymphocyte reaction.

Authors:  S Raziuddin; B Teklu
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

3.  Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.

Authors:  R H Stevens; A Saxon
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

4.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Generalised cytomegalovirus infection in a case with combined immuno-deficiency.

Authors:  C Chowdhury; K Verma
Journal:  Indian J Pediatr       Date:  1980 Jul-Aug       Impact factor: 1.967

6.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  Use of a human plaque-forming cell assay to study peripheral blood bursa-equivalent cell activation and excessive suppressor cell activity in humoral immunodeficiency.

Authors:  H G Herrod; R H Buckley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.

Authors:  I O Auer; E Ziemer
Journal:  Klin Wochenschr       Date:  1980-08-01

9.  Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency.

Authors:  K C Rich; C M Richman; E Mejias; P Daddona
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings.

Authors:  M E Conley; R H Buckley; R Hong; C Guerra-Hanson; C M Roifman; J A Brochstein; S Pahwa; J M Puck
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.